CFF: Path to a Cure Pioneer Award
Cystic Fibrosis Foundation
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Feb 2, 2026
- Closes
- Rolling; current round closes Dec 5, 2026 (in 77 days)
Similar opportunities open now
- CFF: Student Traineeship AwardSame funderOpenCystic Fibrosis FoundationCloses Nov 16, 2026 (in 58 days)Up to $4K
- CFF: Travel Award SupplementSame funderOpenCystic Fibrosis FoundationCloses Nov 16, 2026 (in 58 days)Up to $3K
- CFF: CFF/NIH R01 Unfunded AwardSame funderOpenCystic Fibrosis FoundationCloses Nov 30, 2026 (in 72 days)Up to $125K
- Sparking Interest in Pathology AwardOpenCAP Foundation Grants and Awards Application SiteCloses Dec 1, 2026 (in 73 days)Up to $500
- Clinical Laboratory Science Investigator AwardOpenCAP Foundation Grants and Awards Application SiteCloses Oct 23, 2026 (in 34 days)Up to $5K
Amount
Amount not published by the funder
Who can apply
Path to a Cure — Pioneer Award The goal of this request for applications is to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. 3 min read In this article This award is intended for exceptional investigators who have made significant, impactful contributions to their field of research. Academic programs supported through the Path to a Cure: Pioneer Award will focus on two core strategies to address the underlying cause of cystic fibrosis: Restoring CFTR protein Successfully restoring CFTR protein production when none is present would enable chloride transport in and out of cells, increasing fluid at the cell surface, and reducing or thinning the thick, sti...
About this opportunity
Purpose: To support paradigm-shifting technologies that have the potential to cure CF at the cellular and/or genetic level The goal of this request for applications is to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. This award is intended for exceptional investigators who have made significant, impactful contributions to their field of research. Academic programs supported through the Path to a Cure: Pioneer Award will focus on two core strategies to address the underlying cause of cystic fibrosis: